Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2023-10-20 | 2023-12-15 | 207722 |
APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-10-20 | 2023-12-15 | 207725 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2023-10-20 | 2023-12-01 | 207728 |
APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-10-27 | 2024-01-05 | 208370 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-10-27 | 2023-11-24 | 208373 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-10-27 | 2024-01-05 | 208376 |
APO-TERIFLUNOMIDE | 14MG | TABLET | Resolved | 2023-10-27 | 2024-01-12 | 208385 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208388 |
APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2023-10-27 | 2023-12-15 | 208397 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2023-10-27 | 2023-11-24 | 208403 |
APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2023-10-27 | 2024-02-09 | 208411 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208414 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2023-10-27 | 2024-01-12 | 208420 |
APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-11-06 | 2024-01-05 | 209333 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-11-06 | 2024-01-05 | 209345 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-11-06 | 2023-12-01 | 209351 |
APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2023-11-06 | 2023-11-10 | 209357 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-11-06 | 2023-12-01 | 209366 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-11-06 | 2024-01-26 | 209369 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |